AI Analysis AI Analysis of BCDA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BCDA to Watchlist?
  • Easy Tracking In The Watchlist
PDF

BioCardia, Inc. stock price took a fall of -6.07% on Friday
(Updated on Jul 24, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026 Loss -0.57%

The BioCardia, Inc. stock price fell by -6.07% on the last day (Friday, 24th Jul 2026) from $0.91 to $0.85. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.06% from a day low at $0.85 to a day high of $0.91. The price has fallen in 7 of the last 10 days and is down by -7.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -148 thousand shares and in total, 125 thousand shares were bought and sold for approximately $106.11 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.25% during the next 3 months and, with a 90% probability hold a price between $0.642 and $1.06 at the end of this 3-month period.

BCDA Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 6.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The BioCardia, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.88 and $0.96. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for BioCardia, Inc. stock

BioCardia, Inc. finds support from accumulated volume at $0.83 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0600 between high and low, or 7.06%. For the last week the stock has had daily average volatility of 8.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCDA) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect BioCardia, Inc. to open at $0.87, and during the day (based on 14 day Average True Range), to move between $0.81 and $0.89, which gives a possible trading interval of +/-$0.0898 (+/-11.15%) up or down from last closing price. If BioCardia, Inc. takes out the full calculated possible swing range there will be an estimated 11.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.83 (2.00%) than the resistance at $0.92 (8.22%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioCardia, Inc. stock A Buy?

BioCardia, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.183 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $0.87 ( 2.34%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BCDA Performance

Trading levels for BCDA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.93 9.40%
R2 0.91 6.71%
R1 0.89 5.04%
Price 0.85
S1 0.85 -0.351%
S2 0.83 -2.02%
S3 0.81 -4.71%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.06 24.69%
R2 1.03 21.16%
R1 0.92 8.22%
Price 0.85
S1 0.83 -2.00%
S2 0.81 -4.72%
S3 0.795 -6.47%

FAQ

What is the symbol for BioCardia, Inc. Stock and on which exchange is it traded?
The symbol for BioCardia, Inc. is BCDA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioCardia, Inc. Stock?
BioCardia, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy BioCardia, Inc. Stock?
BioCardia, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioCardia, Inc. Stock.

What's the current price of BioCardia, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an BioCardia, Inc. (BCDA) share was $0.85.

What is the 52-week high and low for BioCardia, Inc. Stock?
The 52-week high for BioCardia, Inc. Stock is $2.42 and the 52-week low is $0.777.

What is the market capitalization of BioCardia, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of BioCardia, Inc. is 4.93M.

When is the next earnings date for BioCardia, Inc.?
The upcoming earnings date for BioCardia, Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOCARDIA, INC.
BioCardia
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE